Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Good Start Genetics® Announces The Expansion of its NGS-Based Carrier Screening Service

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
The announcement means that Good Start Genetics' screening service, GoodStart Select™, now offers state-of-the-art testing for all 23 of the diseases recommended in guidelines set by the major medical societies.

Good Start's screening services centers on the revolutionary, next- generation DNA sequencing platform - which can detect far more disease-causing mutations than the older, genotyping-based platform - with the goal of providing the highest carrier detection rates possible.

In addition to its menu of pan-ethnic tests (e.g. cystic fibrosis, fragile X syndrome and spinal muscular atrophy), tests for hemoglobinopathies (sickle cell anemia, alpha thalassemia and beta thalassemia) and routine tests for the Ashkenazi Jewish population, Good Start now offers the following additional tests: dihydrolipoamide dehydrogenase deficiency, familial hyperinsulinism, glycogen storage disease type 1a, Joubert syndrome 2, maple syrup urine diseases type A/B, nemaline myopathy, Usher syndrome type 1F, Usher syndrome type III, and Walker-Warburg syndrome.

Good Start performs testing in its CAP- and CLIA-accredited, state-of-the-art laboratory facility located in Cambridge, MA, and has built a dedicated team of customer care specialists, genetic counselors and board certified medical geneticists to support patients and clinics. Good Start works closely with patients and their insurance providers to simplify the billing and payment process. In addition, as part of its mission to provide accurate, simple and responsible testing, Good Start has launched a new web site, which includes patient and physician-friendly tools that facilitate in the test selection process. (Good Start's test menu can be customized for each patient based on family history, patient ethnicity, or any other criteria the clinician deems important.)

"Reproductive healthcare professionals have long followed guideline recommendations for carrier screening for their patients planning pregnancy," said Michael Alper, M.D., Medical Director & Reproductive Endocrinologist, Boston IVF. "However, conventional screening methods have, to date, been limited by either their rigidity or the relatively small number of mutations that can be analyzed in a specific gene. Given recent advancements with the next-generation sequencing technology, we are pleased to be able to offer Good Start's technology to our patients in routine clinical practice."

"We are excited to make these additional tests available, and to meet the growing screening needs of new families and those wishing to start families," said Don Hardison, Good Start Genetics President and Chief Executive Officer. "And, using our next generation sequencing platform, we are already detecting mutations that other laboratories simply cannot. With this powerful technology, combined with our intense customer focus, we are confident we are delivering the best screening experience possible for patients and clinicians and, most importantly, critical information that can help increase a couple's chance of having a healthy baby. As a result, we expect that our sequencing-based approach to screening will continue to replace older, genotyping-based approaches and solidify our reputation as a leader in the carrier screening market."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Viral Comparisons
ORNL team applies genomics expertise to analyze, map virus sequence database.
The Tree of Life — More Like A Bush
New species evolve whenever a lineage splits off into several. Because of this, the kinship between species is often described in terms of a ‘tree of life’, where every branch constitutes a species.
Ancient Origins of Deadly Lassa Virus Uncovered
Working as part of an international team in North America and West Africa, a researcher at The Scripps Research Institute (TSRI) has published new findings showing the ancient roots of the deadly Lassa virus, a relative of Ebola virus, and how Lassa virus has changed over time.
Furthering Data Analysis of Next-gen Sequencing to Facilitate Research
Researchers at Cincinnati Children's Hospital Medical Center have developed a user-friendly, integrated platform for analyzing the transcriptomic and epigenomic "big data.
Statistical Technique Helps Researchers Understand Tumor Makeup, Personalize Cancer Treatments
A new statistical method for analyzing next-generation sequencing (NGS) data that helps researchers study the genome of various organisms such as human tumors and could help bring about personalized cancer treatments has been unveiled.
‘Fishing Expedition’ Nets Nearly Tenfold Increase in Number of Sequenced Virus Genomes
Newly developed computational tool finds 12,500 genomes of viruses that infect microbes.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!